A detailed history of Monashee Investment Management LLC transactions in Biodesix Inc stock. As of the latest transaction made, Monashee Investment Management LLC holds 3,500,879 shares of BDSX stock, worth $5.18 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
3,500,879
Previous 3,260,879 7.36%
Holding current value
$5.18 Million
Previous $4.99 Million 24.89%
% of portfolio
0.8%
Previous 0.71%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.53 - $1.96 $367,200 - $470,400
240,000 Added 7.36%
3,500,879 $6.23 Million
Q2 2024

Aug 12, 2024

BUY
$1.21 - $1.71 $3.95 Million - $5.58 Million
3,260,879 New
3,260,879 $4.99 Million
Q1 2021

May 14, 2021

SELL
$16.87 - $31.21 $1.79 Million - $3.31 Million
-105,980 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$10.89 - $20.16 $1.15 Million - $2.14 Million
105,980 New
105,980 $2.14 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $59.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.